Developmental changes of MPA exposure in children.

about

Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.

P2860

Q38610665-6C92B7A1-4938-4ABC-832B-C1728CFD69E4 Q48133794-E3632FD3-8759-48D9-AC7B-B31331D5DB4C

P2860

Developmental changes of MPA exposure in children.

Item

http://www.wikidata.org/entity/Q50541249

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Developmental changes of MPA exposure in children.

@en

Developmental changes of MPA exposure in children.

@nl

type

Item

label

Developmental changes of MPA exposure in children.

@en

Developmental changes of MPA exposure in children.

@nl

prefLabel

Developmental changes of MPA exposure in children.

@en

Developmental changes of MPA exposure in children.

@nl

P1476

Developmental changes of MPA exposure in children.

@en

P2093

Ana Catalina Alvarez-Elías

http://www.w3.org/2001/XMLSchema#string

Ekaterina Kirilova Todorova

http://www.w3.org/2001/XMLSchema#string

Elisa C Yoo

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients

Pharmacokinetics of mycophenolate mofetil and sirolimus in children.

Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.

Challenges in pediatric transplantation: the impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies.

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.

P2888

s00467-015-3303-3

P304

975-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-015-3303-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Filler

P577

2016-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289601365

http://www.w3.org/2001/XMLSchema#string

P698

26743220

http://www.w3.org/2001/XMLSchema#string

Developmental changes of MPA exposure in children.

about

P2860

P2860

Developmental changes of MPA exposure in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698